U.S. Software Stock News

NYSE:BAX
NYSE:BAXMedical Equipment

Does Baxter International (BAX) Offer Value After A 39% One-Year Share Price Fall

If you are looking at Baxter International and wondering whether the current share price offers value, this article walks through what the numbers are really saying about the stock. The share price recently closed at US$19.57, with returns of 1.0% over both the last 7 days and 30 days, 0.4% year to date, and a 39.1% decline over the last year that sits on top of 53.8% and 71.5% declines over the last 3 and 5 years. Recent coverage around Baxter International has focused on the broad reset in...
NYSE:TXT
NYSE:TXTAerospace & Defense

Textron Ukraine Contract Adds Weight To Defense Role And Valuation Story

Textron secured a $163 million contract to supply armored vehicles and support to Ukraine under the Ukraine Security Assistance Initiative. The agreement expands Textron's role in international defense programs as it provides vehicles and parts for Ukraine's armed forces. The contract represents a material addition to the company’s defense activities at a time of heightened geopolitical focus on Eastern Europe. For investors watching Textron, NYSE:TXT, this contract adds a new layer of...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

Is Alphatec Holdings (ATEC) Offering Value After Recent Share Price Pullback

Wondering whether Alphatec Holdings at around US$15.26 is offering value or just noise? This article walks through what the current share price might really be saying. The stock has seen sharp swings recently, with a 27.2% decline over the last 30 days and a 26.5% decline year to date, yet it still shows a 33.3% return over the past year and 17.2% over three years. These moves sit against a backdrop of ongoing interest in spine and orthopaedic names, where investors often react quickly to...
NYSE:ECG
NYSE:ECGConstruction

What Everus Construction Group (ECG)'s Auditor Switch From Deloitte to KPMG Means For Shareholders

On January 14, 2026, Everus Construction Group’s Audit Committee approved the dismissal of Deloitte & Touche LLP after completion of the 2025 audit and appointed KPMG LLP as the independent registered public accounting firm beginning with the first quarter of 2026. This transition between two major audit firms puts a spotlight on Everus Construction Group’s governance practices and the robustness of its financial reporting oversight. We’ll now examine how the shift from Deloitte to KPMG may...
NYSE:STVN
NYSE:STVNLife Sciences

Assessing Stevanato Group (STVN) Valuation After Recent Share Weakness And Undervalued Fair Value Narrative

Recent share performance and what it might signal Stevanato Group (STVN) has drawn attention after a stretch of weaker share performance, including negative returns over the past week, month, past 3 months and year, prompting investors to reassess what the current price implies. See our latest analysis for Stevanato Group. With the share price at US$16.97, Stevanato Group’s recent 7 day share price return of 11.15% and 30 day and 90 day declines of 18.02% and 34.22% suggest fading momentum,...
NYSE:DTE
NYSE:DTEIntegrated Utilities

Is Regulatory Scrutiny And Affordability Aid Reframing The Investment Case For DTE Energy (DTE)?

DTE Energy has recently faced a series of regulatory and planning developments, from legal action over its proposed Cedar Fields Solar Park to community listening sessions on its long-term resource plan and ongoing scrutiny of its electric rate hike request in Michigan. At the same time, the company is pledging US$15.00 million in energy assistance for vulnerable households, underscoring how regulatory, social and infrastructure decisions are converging on affordability and reliability for...
NYSE:SHW
NYSE:SHWChemicals

Sherwin-Williams Awards Signal Focus On Product Pipeline And Valuation Tension

Sherwin-Williams honored its 2025 Vendor of the Year and Innovative Product award winners at its annual National Sales Meeting. The awards highlight supplier partnerships and new products that the company is spotlighting in its current lineup. This recognition event reflects Sherwin-Williams’ current priorities around product development and operational focus. Sherwin-Williams, listed on NYSE:SHW, is putting supplier relationships and product development in the spotlight with its latest...
NasdaqCM:GEVO
NasdaqCM:GEVOOil and Gas

Is Gevo’s (GEVO) Carbon Removal Push Reframing Its Long-Term Role in Voluntary Markets?

In January 2026, Gevo announced a leadership realignment including the appointment of Alex Clayton as Chief Carbon Officer and highlighted that its North Dakota facility has issued over 500,000 engineered carbon dioxide removal certificates, which are certified for thousand-year permanence. This push into high-integrity carbon removal credits, supported by third-party ratings and the Puro Standard, underpins Gevo’s ambition to be a key player in the voluntary carbon markets. We’ll now...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP) Margin Compression Challenges Bullish Earnings Growth Narrative

Roper Technologies (ROP) has wrapped up FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$4.00, alongside net income of US$428.4 million. The company has seen quarterly revenue move from US$1.88 billion in Q1 2025 to US$2.1 billion in Q4 2025. Quarterly basic EPS has ranged from US$3.08 to US$4.00 over the same period, giving investors a clear view of how the top and bottom line have tracked together through the year. With trailing 12 month net profit margin at 19.4%...
NYSE:SARO
NYSE:SAROAerospace & Defense

Is StandardAero (SARO) Now Pricing In Too Much Growth After Strong 1-Year Rally

Wondering if StandardAero is priced fairly right now or if the market is missing something? This article explains what the current share price might be suggesting about its value. StandardAero shares recently closed at US$33.12, with returns of 3.4% over 7 days, 13.6% over 30 days, 11.7% year to date, and 27.2% over the last year, which may catch the eye of investors watching for changing risk and reward. Recent coverage around StandardAero has focused on its position in the capital goods...
NYSE:TEX
NYSE:TEXMachinery

Is Terex (TEX) Offering Value After Strong Multi Year Share Price Gains

If you have been wondering whether Terex stock is offering good value right now, the numbers behind its current price can tell you a lot about what you are really paying for. Terex recently closed at US$60.47, with returns of 2.5% over the last 7 days, 9.6% over the last month, 9.9% year to date and 30.3% over the last year, as well as 23.4% over 3 years and 76.6% over 5 years. These figures may shape how investors view both potential upside and risk today. Recent coverage around Terex has...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

3 Stocks Estimated To Be Trading At Up To 48.3% Below Intrinsic Value

As the U.S. stock market experiences a period of modest gains, with major indices like the S&P 500 reaching new milestones and investors anticipating key decisions from the Federal Reserve, attention turns to identifying opportunities within this evolving landscape. In such an environment, discerning undervalued stocks can be crucial for investors aiming to capitalize on potential market inefficiencies and intrinsic value disparities.
NasdaqCM:SKYX
NasdaqCM:SKYXElectrical

Insider Picks For January 2026's Top Growth Stocks

As the U.S. market experiences a slight uptick with major indices like the S&P 500 reaching new milestones, investors are keenly observing how upcoming Federal Reserve decisions and tech earnings will impact future trends. In this environment, growth companies with high insider ownership often attract attention, as their alignment of interests between insiders and shareholders can be appealing amid fluctuating market conditions.
NasdaqGS:DH
NasdaqGS:DHHealthcare Services

Definitive Healthcare And 2 Other Promising Penny Stocks

As the U.S. stock market edges higher with the S&P 500 reaching new milestones, investors are keenly watching for signals from the Federal Reserve and major tech earnings that could influence future trends. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for those seeking growth at lower price points. Though considered a niche area, these stocks can shine when backed by solid financial health and fundamentals,...
NYSE:NGVC
NYSE:NGVCConsumer Retailing

Undiscovered Gems in the US Market to Explore This January 2026

As the United States market navigates a period of cautious optimism with key indices like the S&P 500 reaching new heights, investors are closely watching for signals from the Federal Reserve and major tech earnings. Amidst this backdrop, small-cap stocks often present unique opportunities for those looking to explore lesser-known companies that could benefit from broader economic trends and sector-specific catalysts.
NYSE:NTB
NYSE:NTBBanks

Top Dividend Stocks To Consider In January 2026

As the U.S. stock market continues to edge higher, with the S&P 500 reaching new milestones and investor attention focused on Federal Reserve decisions and major tech earnings, dividend stocks remain an attractive option for those seeking steady income amidst market fluctuations. In this environment, a good dividend stock is characterized by its ability to offer consistent payouts and financial stability, providing investors with a reliable income stream even as broader economic conditions...
OTCPK:CNBP
OTCPK:CNBPBanks

Cornerstone Bancorp (OTCPK:CNBP) EPS Growth Outpaces Long Term Trend And Fuels Bullish Narrative

Cornerstone Bancorp (CNBP) closed out FY 2025 with fourth quarter total revenue of US$11.0 million and basic EPS of US$3.14, alongside net income of US$3.09 million that capped off a year of steady profitability. The company has seen quarterly revenue move from US$9.66 million in Q4 FY 2024 to US$11.0 million in Q4 FY 2025, while basic EPS over that same period went from US$3.02 to US$3.14, supported by a trailing twelve month net profit margin of 25.9% versus 25.7% a year earlier. Taken...
NasdaqCM:CAPR
NasdaqCM:CAPRBiotechs

Does FDA’s No-New-Trial Stance on Deramiocel Shift the Bull Case for Capricor Therapeutics (CAPR)?

Capricor Therapeutics recently issued a regulatory update on its Biologics License Application for Deramiocel in Duchenne muscular dystrophy, confirming that the FDA has requested the full Phase 3 HOPE-3 clinical study report and supporting data, but no new clinical trials or patient data. The absence of a request for additional studies, combined with Capricor’s plan to submit the HOPE-3 report in February 2026, places the focus squarely on data interpretation and the potential for a new...
NYSE:ALX
NYSE:ALXRetail REITs

Is It Too Late To Consider Alexander's (ALX) After A 36% One Year Rally?

If you are wondering whether Alexander's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock most recently closed at US$239.55, with a 7 day return of 0.5% decline, a 30 day return of 9.8%, year to date return of 9.5%, and a 1 year return of 36.3%, which naturally raises questions about how much of this is already reflected in the price. These moves sit alongside a 3 year return of 27.7% and a 5...
NYSE:LDOS
NYSE:LDOSProfessional Services

Is Leidos Holdings (LDOS) Still Attractively Priced After A 96% Three-Year Share Price Gain

If you are wondering whether Leidos Holdings at around US$187 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has delivered a 33.6% return over the past year and 96.3% over three years. More recently it has seen a 2.0% decline over 7 days and a 0.7% return over the last month, with a 2.0% return year to date. Investors have been paying close attention to Leidos because of its role as a major government and defense...